WebbVenofer ® (iron sucrose) injection, USP is an established and effective treatment for chronic kidney disease (CKD) patients experiencing iron deficiency anemia (IDA). … WebbThe safety of Injectafer in pediatric patients was evaluated in Study 3. Study 3 was a randomized, active-controlled study in which 40 patients (1 to 12 years of age: 10 patients, 12 to 17 years of age: 30 patients) received Injectafer 15 mg/kg to a maximum single dose of 750 mg (whichever was smaller) on Days 0 and 7 for a maximum total dose of 1500 …
Injectafer: Package Insert - Drugs.com
WebbRecommended dosage for patients weighing less than 50 kg (110 lb ): Give Injectafer in two doses separated by at least 7 days . Give each dose as 15 mg/kg body weight for a … WebbDosage Form Ferric Carbossimaltosio 50Mg/Ml 10Ml 1 Units Parenteral Use Dosage Strength 1 vial EV 10 ml 50 mg/ml Approval Date Brand Name Ferinject Application Number Packaging Presentation Regulatory Information Country of Registration Italy ASK US Upload your Marketing & Sales content VIFOR FRANCE build converse
DailyMed - INJECTAFER- ferric carboxymaltose injection injection ...
Webb16 dec. 2024 · Injectafer® (ferric carboxymaltose injection) is an iron replacement product. For patients weighing 50 kg or more, it is given intravenously (into the vein) by a healthcare provider in two doses of 750 mg each at least 7 days apart, or as a single dose of 15 mg/kg up to a maximum of a 1000 mg dose. WebbInjectafer ® (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who … WebbThe median age of patients who received Injectafer was 14.5 years (range, 1-17); 83% were female; 88% White and 13% Black. The most common adverse reactions (≥4%) were hypophosphatemia, injection site reactions, rash, headache, and vomiting. CLINICAL CONSIDERATIONS IN PREGNANCY. crossword clue for prized possession